Ben Hackett Co-Founded Basalt Health Raises $20M in Series A Funding

The round also saw participation from Frist Cressey Ventures and 25m Health.

The company plans to use the funding to expand its platform from admissions into discharge and payer workflows and grow its sales, marketing, implementation, and engineering teams.

What is Basalt Health?

Basalt Health provides an AI platform that helps healthcare teams manage patient transitions into post-acute care.

The platform reads patient referrals as they arrive through fax, portals, or direct electronic medical record integrations. It evaluates each referral against a facility’s clinical criteria and supports related workflows such as admissions, benefits checks, and prior authorizations.

Read More:Defense Tech Startup Prime Minute Raises $15M in Pre-Seed Funding

By helping care teams process referrals and make placement decisions faster, Basalt aims to reduce administrative work and improve the post-acute care placement process.

How Much Funding Has Basalt Health Raised?

Basalt Health has raised approximately $24.5 million in total funding.

The company raised $20 million in its latest Series A round, led by NEA. The previous funding included its seed round in 2025.

Who Invested in Basalt Health’s Series A?

The Series A round was led by NEA.

Other investors included:

• Frist Cressey Ventures
• 25m Health

Why the Funding Matters

Basalt Health will use the new funding to expand its platform beyond admissions into discharge and payer workflows.

The company will also grow its sales, marketing, implementation, and engineering teams as it expands its platform and customer base.

Who founded Basalt Health?

Basalt Health was founded in 2024 by Ben Hackett and is headquartered in Nashville, Tennessee.

Hackett previously spent nearly a decade at Accolade. His experience with administrative work in healthcare influenced his decision to build technology focused on reducing friction for care teams.

Leadership Comments

“Case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds,” said Ben Hackett, Founder and CEO of Basalt Health. “Basalt turns that uncertainty into fast, defensible decisions.

“Basalt is tackling a massive healthcare challenge with a rare combination of clinical impact, operational value, and rapid adoption," said Blake Wu, Partner at NEA and Basalt Health board member. "The company’s AI-powered platform is becoming essential infrastructure for care teams, and we’re thrilled to continue our partnership with Ben and the Basalt team to transform how patients move into post acute care.”

Market and Business Growth

Basalt Health has been working with Lifepoint Health since its seed round in 2025.

The company has reduced median chart processing time at Lifepoint Health from 8.5 minutes to 1.2 minutes. Basalt is also being implemented across 49 additional Lifepoint markets by the end of 2026.

The company is focused on improving a post-acute care placement process that involves roughly 14 million patients each year.

What Happens Next?

Basalt Health plans to expand its platform into discharge and payer workflows while growing its sales, marketing, implementation, and engineering teams.

The company will also continue expanding its technology and implementation across healthcare organizations.

Read More:PicoJool Raises $27.5M in Series A Funding Led by Socratic Partners